SCHEMBL2878501

SCHEMBL2878501

COC(=O)Oc1sc(Br)cc1NC1CCC2(CC1)OCCO2

nearest known ligand 0.33

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.33
POLB P06746 1/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP2D6 P10635 1/20 0.33
MAPK1 P28482 1/20 0.33
GPR119 Q8TDV5 1/20 0.32
C5AR1 P21730 2/20 0.31
KDM4E B2RXH2 1/20 0.31
HSD17B10 Q99714 1/20 0.31
CUL4A Q13619 1/20 0.31
CYP1A2 P05177 1/20 0.30
GAA P10253 1/20 0.30
CYP2C9 P11712 1/20 0.30
KMT2A Q03164 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2878830 0.82 ALDH1A1 (0.42) ALDH1A1C5AR1KDM4EGAAKMT2A
SCHEMBL102282 0.82 ALDH1A1 (0.36) ALDH1A1POLBCYP3A4CYP2C19CYP2D6
SCHEMBL2876443 0.72 C5AR1 (0.34) C5AR1
SCHEMBL18644291 0.71 ALDH1A1 (0.37) ALDH1A1POLBCYP3A4CYP2C19CYP2D6
SCHEMBL12444721 0.70 ALDH1A1 (0.36) ALDH1A1POLBCYP3A4CYP2C19CYP2D6
SCHEMBL9965180 0.69 RAF1 (0.46)
SCHEMBL101584 0.68 SMN1; SMN2 (0.49) ALDH1A1MAPK1KDM4EHSD17B10GAA
SCHEMBL22452921 0.67 KDM4E (0.48) ALDH1A1POLBKDM4EHSD17B10GAA
SCHEMBL11991433 0.67 YAP1 (0.46) ALDH1A1POLBKDM4EHSD17B10CYP2C9
SCHEMBL2878862 0.67 KDM4E (0.57) ALDH1A1POLBMAPK1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1569929-B9 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS VIROCHEM PHARMA INC (CA) 2011-09-14 EP claimed
EP-1569929-B1 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS VIROCHEM PHARMA INC (CA) 2010-05-05 EP claimed